1Marcellin P,Chang TT,Lim SG,et al.Adefovir dipivoxil forthe treatment of hepatitis B e antigen-positive chronic hepatitisB[].The New England Journal of Medicine.2003
2Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Adefo-vir dipivoxil for the treatment of hepatitis B e antigen-negativechronic hepatitis B[].The New England Journal of Medicine.2003
3Peters M,Hann HW,Martin P,et al.Adefovir dipivoxil(ADV)alone and in combination with lamivudine(LAM)sup-presses YMDD mutant heptitis B virus replication:48 weekpreliminary analysis[abstract NO.845][].Hepatology.2002
4Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Long-termtherapy with adefovir dipivoxil for HBeAg negative chro-nic hepatitis B[].The New England Journal of Medicine.2005
5Schiff E,Lai CL,Neuhaus P,et al.Adefovir dipivoxil for thetreatment of chronic hepatitis B in patients pre-and post-livertransplantation with lamivudine-resistant hepatitis B virus(HBV)patients[Abstrct NO.831][].Hepatology.2002
6Yeo W,Chang PK,Zhong S,et al.Freqency of hepatitis Bvirus reactivation in cancer patients undergoing cytotoxicchemotherapy:A prospective study[].Journal of Medical Virology.2000
7Lai CL,Leung NWY,Teo EK,et al.Result of a one-year in-ternational phaseⅡB comparative trial of telbivudine,lamivu-dine,and the combination,in patients with chronic hepatitis B[].Hepatology.2003
8Liaw YF,Sung JJY,Chow WC,et al.Lamivudine for pa-tients with chronic hepatitis B and advanced liver disease[].The New England Journal of Medicine.2004
5Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
